Literature DB >> 8585532

P-glycoprotein: its role in drug resistance.

V Ling1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8585532     DOI: 10.1016/s0002-9343(99)80283-6

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


× No keyword cloud information.
  10 in total

Review 1.  Clinical pharmacokinetics of vinorelbine.

Authors:  D Levêque; F Jehl
Journal:  Clin Pharmacokinet       Date:  1996-09       Impact factor: 6.447

2.  To use MIBI or not to use MIBI? That is the question when assessing tumour cells.

Authors:  Jean-Luc Moretti; Nathalie Hauet; Meltem Caglar; Olivier Rebillard; Zeynep Burak
Journal:  Eur J Nucl Med Mol Imaging       Date:  2005-07       Impact factor: 9.236

3.  Immunohistochemical evidence that P-glycoprotein in non-small cell lung cancers is associated with shorter survival.

Authors:  H Yokoyama; T Ishida; K Sugio; T Inoue; K Sugimachi
Journal:  Surg Today       Date:  1999       Impact factor: 2.549

4.  Characterization of P-glycoprotein mediated transport of K02, a novel vinylsulfone peptidomimetic cysteine protease inhibitor, across MDR1-MDCK and Caco-2 cell monolayers.

Authors:  Y Zhang; L Z Benet
Journal:  Pharm Res       Date:  1998-10       Impact factor: 4.200

5.  Imaging recognition of multidrug resistance in human breast tumors using 99mTc-labeled monocationic agents and a high-resolution stationary SPECT system.

Authors:  Zhonglin Liu; Gail D Stevenson; Harrison H Barrett; George A Kastis; Michael Bettan; Lars R Furenlid; Donald W Wilson; James M Woolfenden
Journal:  Nucl Med Biol       Date:  2004-01       Impact factor: 2.408

6.  Distinct N-glycan glycosylation of P-glycoprotein isolated from the human uterine sarcoma cell line MES-SA/Dx5.

Authors:  D A Greer; S Ivey
Journal:  Biochim Biophys Acta       Date:  2007-07-19

7.  Molecular analysis of the multidrug transporter, P-glycoprotein.

Authors:  U A Germann; T C Chambers
Journal:  Cytotechnology       Date:  1998-09       Impact factor: 2.058

8.  99mTc-Sestamibi, a sensitive probe for in vivo imaging of P-glycoprotein inhibition by modulators and mdr1 antisense oligodeoxynucleotides.

Authors:  Veronika Jekerle; Jing-Hung Wang; Deborah A Scollard; Raymond M Reilly; Michael Wiese; Micheline Piquette-Miller
Journal:  Mol Imaging Biol       Date:  2006 Nov-Dec       Impact factor: 3.484

9.  MDR1 hypermethylation contributes to the progression of neuroblastoma.

Authors:  Y-Yong Qiu; Bernard L Mirkin; Rama S Dwivedi
Journal:  Mol Cell Biochem       Date:  2007-03-27       Impact factor: 3.842

10.  Mechanisms of the penetration of blood-borne substances into the brain.

Authors:  Masaki Ueno
Journal:  Curr Neuropharmacol       Date:  2009-06       Impact factor: 7.363

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.